Does OLAPARIB Cause Neutrophil count decreased? 205 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 205 reports of Neutrophil count decreased have been filed in association with OLAPARIB (Lynparza). This represents 1.1% of all adverse event reports for OLAPARIB.
205
Reports of Neutrophil count decreased with OLAPARIB
1.1%
of all OLAPARIB reports
24
Deaths
52
Hospitalizations
How Dangerous Is Neutrophil count decreased From OLAPARIB?
Of the 205 reports, 24 (11.7%) resulted in death, 52 (25.4%) required hospitalization, and 41 (20.0%) were considered life-threatening.
Is Neutrophil count decreased Listed in the Official Label?
Yes, Neutrophil count decreased is listed as a known adverse reaction in the official FDA drug label for OLAPARIB.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Neutrophil count decreased?
CLOZAPINE (2,523)
LENALIDOMIDE (2,471)
PALBOCICLIB (2,224)
CYCLOPHOSPHAMIDE (1,985)
CARBOPLATIN (1,734)
PACLITAXEL (1,562)
RITUXIMAB (1,509)
DEXAMETHASONE (1,320)
BEVACIZUMAB (1,225)
POMALIDOMIDE (1,062)
Which OLAPARIB Alternatives Have Lower Neutrophil count decreased Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL